Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-23
2011-08-23
Yu, Melanie J (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C435S007930, C435S007940, C436S501000, C436S811000
Reexamination Certificate
active
08003337
ABSTRACT:
A method for detecting lysosomal storage diseases including the steps of performing an assay for a single species of glycosaminoglycan contained in a specimen and correlating results of the assay with lysosomal storage diseases. A body fluid such as urine or blood can be employed as a specimen. The assay can be performed by use of a polypeptide that is capable of specifically binding to a glycosaminoglycan-containing molecule. The polypeptide may be an antibody, or a polypeptide having an antigen-binding site of an antibody.
REFERENCES:
patent: 4704356 (1987-11-01), Thonar
patent: 5185245 (1993-02-01), Heimer
patent: 5310646 (1994-05-01), Whitley
patent: 5869273 (1999-02-01), Klock
patent: 6291439 (2001-09-01), Klock
patent: 2003/0157580 (2003-08-01), Hochstrasser et al.
patent: 2005/0221407 (2005-10-01), Okamura et al.
patent: 2007/0161074 (2007-07-01), Tomatsu et al.
patent: 2009/0280505 (2009-11-01), Okamura et al.
patent: 0 869 362 (1998-10-01), None
patent: WO 01/94941 (2001-12-01), None
patent: WO 2003/106997 (2003-12-01), None
Calatroni et al., The Glycosaminoglycans of Human Plasma, The Journal of Clinical Investigation, vol. 48, 1969, pp. 332-343.
Bhavanandan et al., Quantitation of urinary glycoasminoglycans with Alcian blue: evaluation of the interference by Tamm-Horsfall glycoprotein, Clinica Chimica Acta 251 (196) 207-214), 1996.
Kongtawelert et al., A new ELISA method for the determination of keratan sulphate peptides in biological fluids employing a monoclonal antibody and labeled avidin biotin technique, Clinica Chimica Acta; 195 (1990) 17-26.
PTO 02-4824 English Translation of Tanaka et al., Detection of urinary keratin sulfate with the use of monoclonal antibody. vol. 19, No. 3-4, pp. 236-237, Ketsugo Soshiki (1997).
Written Opinion Issued in PCT/US03/13517 (Oct. 28, 2004) (Parent Application), 2004.
Tanaka et al., Detection of urinary keratan sulfate with the use of monocional antibody, vol. 19 No. 3-4, pp. 236-237. Ketsugo Soshiki (1997).
Thuy, Le Phuc et al., A new quantitative assay for gglycosaminoglycans, Clinics Chimica Acta. vol. 212, pp. 17-26, 1992.
Joseph Alroy, et al., “Application of lectin histochemistry and carbohydrate analysis to the characterization of lysosomal storage diseases”, Carbohydrate Research, XP 002468988, vol. 213, Jun. 25, 1991, pp. 229-250.
Strongin, Sensitivity, Specificity and Predictive Value of Diagnostic Tests: Definitions and Clinical Applications, Laboratory Diagnosis of Viral Infections, 2ndedition, 1992, pp. 211-219.
Dembure et al., Techniques in Diagnostic Human Biochemical Genetics, A Laboratory Manual, Screening for Mucopolysaccharidoses by Analysis of Urinary Glycosaminoglycans, 1991, pp. 77-86.
Sewell et al., Klin. Wochenschr. Comprehensive Urinary Screening for Inborn Errors of Complex Carbohydrate Metabolism, 57, 1979, 581-585.
Anatole S. Dekaban, “Mucopolysaccharidoses: Relation of Elevated Cerebral Spinal Fluid to Mental Retardation”, Arch Neurol., vol. 28, Jun. 1973, pp. 385-388.
Robert P. Erickson, et al., “Lack of Relationship Between Blood and Urine Levels of Glycosaminoglycans and Lysomal Enzymes”, Biochemical Medicine, vol. 12, No. 4, Apr. 1975, pp. 331-339.
J. Melet, et al., “A Semi-Quantitative Micromethod for the Determination of Free Glycosaminoglycans in Serum. Results From Studies on Serum of Healthy Children of Various Age and Patients Affected byMucopolysaccharidosis”, Clinica Chimica Acta, vol. 108, No. 2, Dec. 8, 1980, 179-188.
B. Macri, et al., “MucopolysaccharidosisVI in a Siamese/Short-Haired European Cat*”, Journal of Veterinary Medicine A Physiology, Pathology, Clinical Medicine, vol. 49, No. 8, Oct. 2002, pp. 438-442.
Pennock, C.A., A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoes, J. Clin.,Path., 1976, 29, pp. 111-123.
John J. Hopwood, et al., “High-Resolution Electrophoresis of Urinary Glycosaminoglycans: An Improved Screening Test for Mucopolysaccharidoses”, Analytical Biochemistry, 1982, vol. 119, pp. 120-127.
S. Byers, at al., “Glycosaminoglycan Accumulation and Excretion in the Mucopolysaccharidoses: Characterization and Basis of a Diagnostic Test for MPS”, Molecular Genetics and Metabolism, 1998, vol. 65, No. 4, pp. 282-290.
Margaret Z. Jones, et al., “Human Mucopolysaccharidosis IIID; Clinical, Biochemical, Morphological and Immunohistochemical Characteristics”, Journal of Neuropathology and Experimental Neurology, vol. 56, No. 10, Oct. 1997, pp. 1158-1167.
Office Action dated Sep. 16, 2010 issued in the corresponding European patent application No. 03724355.7.
Akira Mada, et al., “Utility of a Carbon Column for High-Performance Liquid Chromatographic Separation of Unsaturated Disaccharides Produced from Glycosaminoglycans”, Analytical Sciences, Dec. 1992, vol. 8, pp. 793-797.
Toshihiro Oguma, et al., “Analytical method of chondroitin/dermatan sulfates using high perforamce liquid chromatography/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides”, Biomedical Chromatography, 15: pp. 356-362, 2001.
Toshihiro Oguma, et al., “Analytical Method of Keratan Sulfates by High-Performance Liquid Chromatography/Turbo-lonspray Tandam Mass Spectrometry”, Analytical Biochemistry, 290, pp. 68-73, 2001.
Toshihiro Oguma, et al., “Analytical method of heparan sulfates using high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry”, Journal of Chromatography B, 754, pp. 153-159, 2001.
Hidenao Toyoda, et al., “Determination of human urinary hyalauronic acid, chondroitin sulphate and dermatan sulphate as their unsatured disaccharides by high-performance liquid chromatography”, Journal of Chromatography, 565, pp. 141-148, 1991.
Office Action mailed Jul. 16, 2009, in co-pending U.S. Appl. No. 11/616,586, Jul. 16, 2009.
U.S. Appl. No. 12/843,439, filed Jul. 26, 2010, Tomatsu, et al.
Miyaura Shuichi
Okamura Kazuo
Tomatsu Shunji
Counts Gary W
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Saint Louis University
Seikagaku Corporation
Yu Melanie J
LandOfFree
Method for detecting lysosomal storage diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting lysosomal storage diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting lysosomal storage diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2677106